Non–Small Cell Lung Cancer: Recommendations for Biomarker Testing …
https://jnccn.org/view/journals/jnccn/19/5.5/article-p610.xml
WebMay 17, 2021 · Biomarker testing is now recommended in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) for all appropriate patients with newly diagnosed stage IV disease, and can be considered for those with squamous histology, explained Dara L. Aisner, MD, PhD, Associate …
DA: 62 PA: 97 MOZ Rank: 88